Natixis Investment Managers International’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,706
| Closed | -$1.6M | – | 415 |
|
|
2022
Q2 | $1.6M | Sell |
2,706
-643
| -19% | -$380K | 0.03% | 166 |
|
|
2022
Q1 | $2.34M | Buy |
+3,349
| New | +$2.34M | 0.04% | 115 |
|
|
2018
Q4 | – | Sell |
-3,815
| Closed | -$1.54M | – | 449 |
|
|
2018
Q3 | $1.54M | Buy |
3,815
+1,672
| +78% | +$675K | 0.07% | 255 |
|
|
2018
Q2 | $739K | Buy |
2,143
+1,829
| +582% | +$631K | 0.04% | 335 |
|
|
2018
Q1 | $108K | Buy |
+314
| New | +$108K | 0.01% | 407 |
|
|
2017
Q4 | – | Sell |
-1,524
| Closed | -$681K | – | 319 |
|
|
2017
Q3 | $681K | Hold |
1,524
| – | – | 0.06% | 222 |
|
|
2017
Q2 | $749K | Hold |
1,524
| – | – | 0.07% | 235 |
|
|
2017
Q1 | $591K | Buy |
+1,524
| New | +$591K | 0.05% | 233 |
|
|
2016
Q2 | – | Sell |
-370
| Closed | -$133K | – | 395 |
|
|
2016
Q1 | $133K | Sell |
370
-692
| -65% | -$249K | 0.02% | 338 |
|
|
2015
Q4 | $577K | Sell |
1,062
-639
| -38% | -$347K | 0.07% | 133 |
|
|
2015
Q3 | $791K | Buy |
1,701
+512
| +43% | +$238K | 0.11% | 133 |
|
|
2015
Q2 | $607K | Buy |
+1,189
| New | +$607K | 0.07% | 164 |
|